In Vivo Effects of Neonatal Administration O Antiidiotype Antibodies on Experimental Autoimmune Myasthenia Gravis

References

• Lindstrom J, Shelton D, Fujii Y. Myasthenia Gravis. Adv Immunol 1988; 233–84
   PubMed Web of Science ®Google Scholar
• Kao I, Drachman D B. Thymic muscle cells bear acelylcholine receptors: possible relation to myasthenia gravis. Science 1976; 195: 74–5
   Web of Science ®Google Scholar
• Stefansson K, Dieperdink M E, Richman D P, Gomez C M, Marton L S. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichiae coli, Proteus vulgaris, and Klebsiella pneumoniae. N Engl J Med 1985; 312: 221–25
   PubMed Web of Science ®Google Scholar
• Stefansson K, Dieperdink M E, Richman D P, Marlon L S. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis. Proc Natl Acad Sci 1987; 505: 451–60
   Google Scholar
• Dwyer D S, Vakil M, Kearney J F. Idiotypic network connectivity and a possible cause of myasthenia gravis. J Exp Med 1986; 164: 1310–318
   PubMed Web of Science ®Google Scholar
• Roitt I M, Male D K, Cooke A, Lydyard P M. Idiotypes and autoimmunity. Springer Sem Immunopathol 1983; 6: 51–66
   PubMed Web of Science ®Google Scholar
• Jerne N K. Towards a network theory of the immune system. Ann Immunol 1974; 125C: 373–89
   PubMedGoogle Scholar
• Ascolla R S, Gearhart P J, Sigal N H, Cancro M P, Klinman N R. Idiotype-specific neonatal suppression of phosphorylcholine-responsive B cells. Eur J Immunol 1977; 7: 876–81
   PubMed Web of Science ®Google Scholar
• Fung J, Köhler H. Mechanism of neonatal idiotype suppression I. State of suppressed B cells. J Immunol 1980; 125: 1998–2003
   PubMed Web of Science ®Google Scholar
• Hiernaux J, Bona C, Baker P J. Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. J Exp Med 1981; 153: 1004–8
   PubMed Web of Science ®Google Scholar
• Souroujon M C, Fuchs S. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis. Ann N Y Acad Sci 1985; 475: 81–93
   Web of Science ®Google Scholar
• Agius M A, Richman D P. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal antiidiotypic antibody. J Immunol 1986; 137: 2195–98
   PubMed Web of Science ®Google Scholar
• Dwyer D S, Schonbeck S. Anti-idiotypic regulation of the immune response against the acetylcholine receptor. Imm Reg Char Peptides 1987; 607–16
   Google Scholar
• Lennon V A, Lambert E H. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann N Y Acad Sci 1981; 377: 77–96
   PubMed Web of Science ®Google Scholar
• Killen J A, Hochschwender S M, Lindstrom J M. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotype. J Neuroimmunol 1985; 9: 229–41
   PubMed Web of Science ®Google Scholar
• Reth M, Kelsoe G, Rajewsky K. Idiotypic regulation by isologous monoclonal anti-idiotope antibodies. Nature 1981; 290: 257–59
   PubMed Web of Science ®Google Scholar
• Takemori T, Rajewsky K. Specificity, duration and mechanism of idiotype suppression induced by neonatal injection of monoclonal anti-idiotope antibodies into mice. Eur J Immunol 1984; 14: 656–67
   PubMed Web of Science ®Google Scholar
• Strayer D S, Lee W MF, Rowley D A, Köhler H. Anti-receptor antibody II. Induction of longterm unresponsiveness in neonatal mice. J Immunol 1975; 114: 728–33
   PubMed Web of Science ®Google Scholar
• Lindstrom J, Anholt R, Einarson B, Engel Osame M, Montal M. Purification of acetylcholine receptors, reconstitution into lipid vesicles, and study of agonist-induced cation channel regulation. J Biol Chem 1980; 255: 8340–350
   PubMed Web of Science ®Google Scholar
• Lindstrom M J, Einarson B L, Lennon V A, Seybold M E. Pathological mechanisms in experimental autoimmune myasthenia gravis. Immunogenicity of syngeneic acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J Exp Med 1976; 144: 726–38
   PubMed Web of Science ®Google Scholar
• Verschuuren J JGM, Graus Y MF, Tzartos S J, van Breda Vriesman P JC, De Baets M H. Paratope and framework related crossreactive idiotopes on acetylcholine receptor antibodies. J Immunol 1991; volume 146: 941–948
   Web of Science ®Google Scholar
• Lennon V A, Lindstrom J, Seybold M E. Experimental autoimmune myasthenia gravis: a model of myasthenia gravis in rats and guinea pigs. J Exp Med 1975; 141: 1365–75
   PubMed Web of Science ®Google Scholar
• Swinscow T DV. Statistics at square one. British Medical Association, London 1978
   Google Scholar
• Augustin A, Cosenza H. Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur J Immunol 1976; 6: 497–501
   PubMed Web of Science ®Google Scholar
• Bona C, Stein K E, Lieberman R, Paul W. Direct and indirect suppression induced by anti-idiotype antibody in the inulin-bacterial levan antigenic system. Mol Immunol 1979; 16: 1093–101
   PubMed Web of Science ®Google Scholar
• Kearney J F, Vakil M. Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol Rev 1986; 94: 39–50
   PubMed Web of Science ®Google Scholar
• Brown A R, Sealy R E. Regulation of the BALB/c anti-p-azophenylarsonate antibody response by monoclonal anti-idiotype. II. Idiotype expression in serum and its regulation. J Immunol 1986; 137: 610–17
   PubMed Web of Science ®Google Scholar
• Zanetti M, Glotz D, Rogers J. Pertubation of the autoimmune network. II. Immunization with isologous idiotype induces auto-anti-idiotypic antibodies and suppresses the autoantibody response elicited by antigen: a serologic and cellular analysis. J Immunol 1986; 137: 3140–46
   PubMed Web of Science ®Google Scholar
• Kelsoe G, Reth M, Rajewsky K. Control of idiotope expression by monoclonal anti-idiotope and idiotope-bearing antibody. Eur J Immunol 1981; 11: 418–23
   PubMed Web of Science ®Google Scholar
• Eichmann K. Idiotype suppression. I. Influence of the dose and of the effector functions of anti-idiotypic antibody on the production of an idiotype. Eur J Immunol 1974; 4: 296–302
   PubMedGoogle Scholar
• Zanetti M, Bigazzi P E. Anti-idiotypic immunity and autoimmunity. I. In vitro and in vivo effects of anti-idiotypic antibodies to spontaneously occuring autoantibodies to rat thyroglobulin. Eur J Immunol 1981; 11: 187–95
   PubMed Web of Science ®Google Scholar
• Berek C. Antibodies specific for different T15 idiotopes induce neonatal suppression of the T15 idiotype. Eur J Immunol 1983; 13: 766–72
   PubMed Web of Science ®Google Scholar
• Zanetti M, Mampaso F, Wilson C B. Anti-idiotype as a probe in the analysis of autoimmune tubulointerstitial nephritis in the Brown Norway rat. J Immunol 1983; 131: 1268–73
   PubMed Web of Science ®Google Scholar
• Neilson E G, Philips M S. Suppression of interstitial nephritis by auto-anti-idiotypic immunity. J Exp Med 1982; 155: 179–89
   PubMed Web of Science ®Google Scholar
• Hahn B H, Ebling F M. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol 1984; 132: 187–90
   PubMed Web of Science ®Google Scholar